Aptose to Report Second Quarter 2022 Financial Results and Hold Conference Call on Tuesday, August 2, 2022 Jul 19, 2022 4:01pm EDT
Aptose Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer Jun 27, 2022 7:30am EDT
Aptose Receives Fast Track Designation for HM43239 in Relapsed/Refractory AML Patients and FLT3 Mutation May 04, 2022 7:30am EDT
